STE
Price
$238.79
Change
+$0.26 (+0.11%)
Updated
Jun 27 closing price
Capitalization
22.22B
43 days until earnings call
XRAY
Price
$15.93
Change
-$0.07 (-0.44%)
Updated
Jun 27 closing price
Capitalization
6.69B
32 days until earnings call
Interact to see
Advertisement

STE vs XRAY

Header iconSTE vs XRAY Comparison
Open Charts STE vs XRAYBanner chart's image
STERIS
Price$238.79
Change+$0.26 (+0.11%)
Volume$741.59K
Capitalization22.22B
DENTSPLY SIRONA
Price$15.93
Change-$0.07 (-0.44%)
Volume$3.05M
Capitalization6.69B
STE vs XRAY Comparison Chart in %
Loading...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STE vs. XRAY commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STE is a Buy and XRAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (STE: $238.79 vs. XRAY: $15.93)
Brand notoriety: STE and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: STE: 112% vs. XRAY: 110%
Market capitalization -- STE: $22.22B vs. XRAY: $6.69B
STE [@Medical Specialties] is valued at $22.22B. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STE’s FA Score shows that 1 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • STE’s FA Score: 1 green, 4 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, STE is a better buy in the long-term than XRAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STE’s TA Score shows that 2 TA indicator(s) are bullish while XRAY’s TA Score has 3 bullish TA indicator(s).

  • STE’s TA Score: 2 bullish, 4 bearish.
  • XRAY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both STE and XRAY are a bad buy in the short-term.

Price Growth

STE (@Medical Specialties) experienced а +1.32% price change this week, while XRAY (@Medical Specialties) price change was +4.76% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.14%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was -0.01%.

Reported Earning Dates

STE is expected to report earnings on Aug 11, 2025.

XRAY is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+1.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STE($22.2B) has a higher market cap than XRAY($6.69B). STE has higher P/E ratio than XRAY: STE (38.85) vs XRAY (19.23). STE YTD gains are higher at: 16.740 vs. XRAY (-14.346). STE has higher annual earnings (EBITDA): 1.39B vs. XRAY (249M). XRAY has more cash in the bank: 334M vs. STE (196M). XRAY has less debt than STE: XRAY (2.3B) vs STE (3.51B). STE has higher revenues than XRAY: STE (5.41B) vs XRAY (3.97B).
STEXRAYSTE / XRAY
Capitalization22.2B6.69B332%
EBITDA1.39B249M560%
Gain YTD16.740-14.346-117%
P/E Ratio38.8519.23202%
Revenue5.41B3.97B136%
Total Cash196M334M59%
Total Debt3.51B2.3B153%
FUNDAMENTALS RATINGS
STE vs XRAY: Fundamental Ratings
STE
XRAY
OUTLOOK RATING
1..100
7617
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
44100
SMR RATING
1..100
7097
PRICE GROWTH RATING
1..100
5062
P/E GROWTH RATING
1..100
5589
SEASONALITY SCORE
1..100
n/a30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (3) in the Medical Specialties industry is in the same range as STE (19). This means that XRAY’s stock grew similarly to STE’s over the last 12 months.

STE's Profit vs Risk Rating (44) in the Medical Specialties industry is somewhat better than the same rating for XRAY (100). This means that STE’s stock grew somewhat faster than XRAY’s over the last 12 months.

STE's SMR Rating (70) in the Medical Specialties industry is in the same range as XRAY (97). This means that STE’s stock grew similarly to XRAY’s over the last 12 months.

STE's Price Growth Rating (50) in the Medical Specialties industry is in the same range as XRAY (62). This means that STE’s stock grew similarly to XRAY’s over the last 12 months.

STE's P/E Growth Rating (55) in the Medical Specialties industry is somewhat better than the same rating for XRAY (89). This means that STE’s stock grew somewhat faster than XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STEXRAY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
56%
Bullish Trend 3 days ago
56%
MACD
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
72%
Advances
ODDS (%)
N/A
Bullish Trend 20 days ago
58%
Declines
ODDS (%)
Bearish Trend 10 days ago
49%
Bearish Trend 17 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
56%
Aroon
ODDS (%)
Bearish Trend 3 days ago
42%
Bearish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIGOX31.330.40
+1.29%
Marsico Global Institutional
GFACX69.770.57
+0.82%
American Funds Growth Fund of Amer C
JCNNX28.640.20
+0.70%
Janus Henderson Contrarian N
NSOIX16.830.05
+0.30%
North Star Opportunity I
MFWHX17.520.05
+0.29%
MFS Global Total Return R3

STE and

Correlation & Price change

A.I.dvisor indicates that over the last year, STE has been loosely correlated with SYK. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STE
1D Price
Change %
STE100%
+0.11%
SYK - STE
55%
Loosely correlated
+0.81%
WAT - STE
53%
Loosely correlated
-0.70%
LH - STE
51%
Loosely correlated
+1.40%
DHR - STE
51%
Loosely correlated
-1.16%
RVTY - STE
51%
Loosely correlated
-0.98%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
+0.57%
NVST - XRAY
54%
Loosely correlated
N/A
QDEL - XRAY
50%
Loosely correlated
+0.59%
STE - XRAY
47%
Loosely correlated
+0.11%
KIDS - XRAY
46%
Loosely correlated
-1.84%
AZTA - XRAY
45%
Loosely correlated
-0.58%
More